Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis

Tissue Engineering - Part C: Methods

Volumn 18, Issue 1, 2012, Pages 21-32

  Hayakawa, Tomohiro ^a   Kunihiro, Takeshi ^b   Dowaki, Suguru ^a   Uno, Hatsume ^a   Matsui, Eriko ^a   Uchida, Masashi ^b   Kobayashi, Seiji ^b   Yasuda, Akio ^a   Shimizu, Tatsuya ^c   Okano, Teruo ^c  

^a SONY CORPORATION   (Japan)

^b Technology Development Group   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; IMAGE MATCHING; MONOLAYERS; NONINVASIVE MEDICAL PROCEDURES; POTASSIUM; RELAXATION PROCESSES; TISSUE;

1-HEPTANOL; BLOCK MATCHING ALGORITHMS; CARDIOMYOCYTES; CHANNEL BLOCKERS; CONTRACTILE BEHAVIOR; COOPERATIVITY; FLUORESCENCE MEASUREMENTS; GAP JUNCTIONS; INTRACELLULAR CA; MOTION VECTOR ANALYSIS; MOTION VECTORS; NONINVASIVE METHODS; PHASE-CONTRAST IMAGING; PROPAGATION PATTERN; Q WAVES; SHORTENING VELOCITY; SPATIO-TEMPORAL RESOLUTION; T WAVES; TERFENADINE; TIME DEPENDENCE; VIDEO IMAGE;

VECTORS;

CALCIUM; POTASSIUM CHANNEL BLOCKING AGENT;

ALGORITHM; ANIMAL; ARTICLE; CYTOLOGY; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; METABOLISM; METHODOLOGY; MOTION; MUSCLE CONTRACTION; PHASE CONTRAST MICROSCOPY; RAT; SPRAGUE DAWLEY RAT; STATISTICAL MODEL; TISSUE ENGINEERING; VIDEO MICROSCOPY;

ALGORITHMS; ANIMALS; CALCIUM; IMMUNOHISTOCHEMISTRY; MICROSCOPY, PHASE-CONTRAST; MICROSCOPY, VIDEO; MODELS, STATISTICAL; MOTION; MUSCLE CONTRACTION; MYOCYTES, CARDIAC; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; TISSUE ENGINEERING;

EID: 84855362203     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2011.0273     Document Type: Article

References (48)

1. Yoshida, Y., and Yamanaka, S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 50, 327, 2011.
2. Fukuda, K., and Yuasa, S. Stem cells as a source of regenerative cardiomyocytes. Circ Res 98, 1002, 2006.
3. Witchel, H.J. Emerging trends in ion channel-based assays for predicting the cardiac safety of drugs. IDrugs 13, 90, 2010.
4. Steel, D., Hyllner, J., and Sartipy, P. Cardiomyocytes derived from human embryonic stem cells-characteristics and utility for drug discovery. Curr Opin Drug Discov Devel 12, 133, 2009.
5. Liang, H., Matzkies, M., Schunkert, H., Tang, M., Bonnemeier, H., Hescheler, J., and Reppel, M. Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening. Cell Physiol Biochem 25, 459, 2010.
6. Krawetz, R., Taiani, J.T., Liu, S., Meng, G., Li, X., Kallos, M.S., and Rancourt, D.E. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods 16, 573, 2010.
7. He, J.Q., Ma, Y., Lee, Y., Thomson, J.A., and Kamp, T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93, 32, 2003.
8. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L.S., Nguemo, F., Menke, S., Haustein, M., Hescheler, J., Hasenfuss, G., and Martin, U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507, 2008.
9. Zhang, J., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J., Palecek, S.P., Thomson, J.A., and Kamp, T.J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104, e30, 2009.
10. Shimoji, K., Yuasa, S., Onizuka, T., Hattori, F., Tanaka, T., Hara, M., Ohno, Y., Chen, H., Egasgira, T., Seki, T., Yae, K., Koshimizu, U., Ogawa, S., and Fukuda, K. G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 6, 227, 2010.
11. Hattori, F., Chen, H., Yamashita, H., Tohyama, S., Satoh, Y.S., Yuasa, S., Li, W., Yamakawa, H., Tanaka, T., Onitsuka, T., Shimoji, K., Ohno, Y., Egashira, T., Kaneda, R., Murata, M., Hidaka, K., Morisaki, T., Sasaki, E., Suzuki, T., Sano, M., Makino, S., Oikawa, S., and Fukuda, K. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7, 61, 2010.
12. Webb, S. Burgeoning stem cell product market lures major suppliers. Nat Biotechnol 28, 535, 2010.
13. Moretti, A., Bellin, M., Welling, A., Jung, C.B., Lam, J.T., Bott-Flugel, L., Dorn, T., Goedel, A., Hohnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schomig, A., and Laugwitz, K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Eng J Med 363, 1397, 2010.
14. Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., and Gepstein, L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225, 2011.
15. Hossain, M.M., Shimizu, E., Saito, M., Rao, S.R., Yamaguchi, Y., and Tamiya, E. Non-invasive characterization of mouse embryonic stem cell derived cardiomyocytes based on the intensity variation in digital beating video. Analyst 135, 1624, 2010.
16. Stummann, T.C., Wronski, M., Sobanski, T., Kumpfmueller, B., Hareng, L., Bremer, S., and Whelan, M.P. Digital movie analysis for quantification of beating frequencies, chronotropic effects, and beating areas in cardiomyocyte cultures. Assay Drug Dev Technol 6, 375, 2008.
17. Bers, D.M. Cardiac excitation-contraction coupling. Nature 415, 198, 2002.
18. Bers, D.M. Excitation-Contraction Coupling and Cardiac Contractile Force. Boston: Kluwer, 2001.
19. Bers, D.M. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70, 23, 2008.
20. Koseki, N., Deguchi, J., Yamada, T., Funabashi, H., and Seki, T. Usefulness of field potential as a marker of embryonic stem cell-derived cardiomyocytes, and endpoint analysis of embryonic stem cell test. J Toxicol Sci 35, 899, 2010.
21. Chang, M.G., Zhang, Y., Chang, C.Y., Xu, L., Emokpae, R., Tung, L., Marban, E., and Abraham, M.R. Spiral waves and reentry dynamics in an in vitro model of the healed infarct border zone. Circ Res 105, 1062, 2009.
22. Nakagami, T., Tanaka, H., Dai, P., Lin, S.F., Tanabe, T., Mani, H., Fujiwara, K., Matsubara, H., and Takamatsu, T. Generation of reentrant arrhythmias by dominant-negative inhibition of connexin43 in rat cultured myocyte monolayers. Cardiovasc Res 79, 70, 2008.
23. Ghanbari, M. The cross-search algorithm for motion estimation. IEEE Trans Commun 38, 950, 1990.
24. de Tombe, P.P., and ter Keurs, H.E. Force and velocity of sarcomere shortening in trabeculae from rat heart. Effects of temperature. Circ Res 66, 1239, 1990.
25. McDonald, K.S., Wolff, M.R., and Moss, R.L. Force-velocity and power-load curves in rat skinned cardiac myocytes. J Physiol 511 (Pt 2), 519, 1998.
26. Nishimura, S., Yasuda, S., Katoh, M., Yamada, K.P., Yamashita, H., Saeki, Y., Sunagawa, K., Nagai, R., Hisada, T., and Sugiura, S. Single cell mechanics of rat cardiomyocytes under isometric, unloaded, and physiologically loaded conditions. Am J Physiol Heart Circ Physiol 287, H196, 2004.
27. Fitzsimons, D.P., Patel, J.R., and Moss, R.L. Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. The Journal of physiology 513 (Pt 1), 171, 1998.
28. Korth, M., and Kuhlkamp, V. Muscarinic receptors mediate negative and positive inotropic effects in mammalian ventricular myocardium: differentiation by agonists. Br J Pharmacol 90, 81, 1987.
29. Boyett, M.R., Kirby, M.S., Orchard, C.H., and Roberts, A. The negative inotropic effect of acetylcholine on ferret ventricular myocardium. J Physiol 404, 613, 1988.
30. Takemura, H., Kimura, H., Hatta, S., Amemiya, N., Kawana, S., Imoto, K., and Ohshika, H. Alpha 1-and beta-adrenergic and muscarinic-cholinergic regulation in the spontaneous beating and Ca2 + oscillations in cultured neonatal rat cardiac myocytes. Life Sci 59, PL221, 1996.
31. Colecraft, H.M., Egamino, J.P., Sharma, V.K., and Sheu, S.S. Signaling mechanisms underlying muscarinic receptor-mediated increase in contraction rate in cultured heart cells. J Biol Chem 273, 32158, 1998.
32. Endoh, M., Hiramoto, T., Ishihata, A., Takanashi, M., and Inui, J. Myocardial alpha 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ Res 68, 1179, 1991.
33. Terzic, A., Puceat, M., Vassort, G., and Vogel, S.M. Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev 45, 147, 1993.
34. Sanguinetti, M.C., and Jurkiewicz, N.K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96, 195, 1990.
35. Berul, C.I., and Morad, M. Regulation of potassium channels by nonsedating antihistamines. Circulation 91, 2220, 1995.
36. Miller, K.E., Carpenter, J.F., and Brooks, R.R. Inhibition of isoproterenol-induced tachycardia by azimilide in the isolated perfused guinea pig heart. Cardiovasc Drugs Ther 12, 83, 1998.
37. Yan, G.X., and Antzelevitch, C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 98, 1928, 1998.
38. Antzelevitch, C. Ionic, molecular, and cellular bases of QTinterval prolongation and torsade de pointes. Europace 9 Suppl 4, iv4, 2007.
39. Guo, J., Massaeli, H., Li, W., Xu, J., Luo, T., Shaw, J., Kirshenbaum, L.A., and Zhang, S. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes. J Pharmacol Exp Ther 321, 911, 2007.
40. Yue, D.T., Marban, E., and Wier, W.G. Relationship between force and intracellular [Ca2 +[ in tetanized mammalian heart muscle. J Gen Physiol 87, 223, 1986.
41. Cleemann, L., and Morad, M. Role of Ca2 + channel in cardiac excitation-contraction coupling in the rat: evidence from Ca2 + transients and contraction. J Physiol 432, 283, 1991.
42. Yamamoto, Y., Fukuta, H., Nakahira, Y., and Suzuki, H. Blockade by 18beta-glycyrrhetinic acid of intercellular electrical coupling in guinea-pig arterioles. J Physiol 511 (Pt 2), 501, 1998.
43. Rozental, R., Srinivas, M., and Spray, D.C. How to close a gap junction channel. Efficacies and potencies of uncoupling agents. Methods Mol Biol 154, 447, 2001.
44. Zaniboni, M., Rossini, A., Swietach, P., Banger, N., Spitzer, K.W., and Vaughan-Jones, R.D. Proton permeation through the myocardial gap junction. Circ Res 93, 726, 2003.
45. Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A., Umezu, M., and Okano, T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90, e40, 2002.
46. Eschenhagen, T., and Zimmermann, W.H. Engineering myocardial tissue. Circ Res 97, 1220, 2005.
47. Bian, W., Liau, B., Badie, N., and Bursac, N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc 4, 1522, 2009.
48. Hansen, A., Eder, A., Bonstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schworer, A., Uebeler, J., and Eschenhagen, T. Development of a drug screening platform based on engineered heart tissue. Circ Res 107, 35, 2010.